Temporal lobe epilepsy (TLE) is the most common of the acquired epilepsies and is characterized by an initial injury that eventually leads to the development of chronic seizures, during a process known as epileptogenesis. It is known that mitochondrial dysfunction and increased levels of reactive oxygen species contribute to enhanced neuronal excitability during the development of chronic seizures. However, the etiology of the metabolic dysfunction and oxidative stress are unknown. A potential unifying mechanism linking these bioenergetic and redox changes in the development of epilepsy is dysregulation of sirtuin 3 (SIRT3). This proposal will investigate 1) the loss of the activity of SIRT3 and its substrates during epileptogenesis as a result of aberrant mitochondrial hyperacetylation, 2) the potential efficacy of SIRT3 activation on attenuating the development of chronic epilepsy by restoring metabolic and mitochondrial homeostasis, and 3) the effects of neuronal deletion of SIRT3 on epilepsy development and impairments in mitochondrial bioenergetics. These studies will utilize novel metabolic and neuronal techniques to assess multiple parameters of neurometabolism in epilepsy models. Further, this proposal will investigate an innovative therapy to reduce or prevent the progression of epileptogenesis. The results from the proposed studies will provide novel insight into the mechanisms underlying the development of chronic epilepsy and may lead to the development of new therapies to attenuate the progression of this neurodegenerative disease.

Public Health Relevance

The proposed research will provide new insight into the pathways by which metabolic and mitochondrial dysfunction arise with the development of epilepsy, as well as the efficacy of a novel therapeutic strategy to attenuate the progression of this neurodegenerative disease. These studies could result in a much-needed novel treatment for reducing the development of chronic epilepsy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32NS090808-01A1
Application #
8983866
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Whittemore, Vicky R
Project Start
2015-12-31
Project End
2017-12-30
Budget Start
2015-12-31
Budget End
2016-12-30
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Heischmann, Svenja; Gano, Lindsey B; Quinn, Kevin et al. (2018) Regulation of kynurenine metabolism by a ketogenic diet. J Lipid Res 59:958-966
Gano, Lindsey B; Liang, Li-Ping; Ryan, Kristen et al. (2018) Altered mitochondrial acetylation profiles in a kainic acid model of temporal lobe epilepsy. Free Radic Biol Med 123:116-124